- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01112904
Essential Fatty Acid (EFA) Nutrition 5-Year-Olds Follow-Up Study
n-3 Fatty Acids and Early Child Nutrition: 5-Year-Olds Follow-Up Study
Docosahexanoic acid (DHA) is concentrated in the human brain. Before birth, DHA is transferred across the placenta, but transfer depends on maternal DHA intake. After birth, DHA is provided by breast milk or the child's diet. This study addresses whether DHA intakes are adequate to support human brain development.
In a previous study "N-3 Fatty Acid Requirements for Human Development" (C03-0242), pregnant women were randomly assigned to 400 mg/day DHA or placebo from 16 weeks of gestation until infant delivery. Blood DHA in gestation, and infant development to 18 months were assessed. This follow-up study will assess if maternal DHA in gestation has long-term influence on child development when assessed at 5 years and the impact of the child's own diet.
Study Overview
Status
Conditions
Detailed Description
This research is a prospective follow-up on an existing cohort of women and their children to determine whether dietary intakes of docosahexaenoic acid (DHA) during pregnancy have effects lasting into early childhood. The purpose of this study is to assess the relationship between maternal DHA status in gestation, which is known, and the child 's own diet and relevant genetic variables on the child's neural, cognitive and behavioral development. Hypotheses: 1. maternal DHA status in gestation has a lasting effect on infant development evident when assessed in early childhood 2. Children with low DHA status will be at increased risk for poor scores on tests of development. 3. Genetic variation in fatty acid metabolism will influence blood fatty acids in preschool children.
Objectives: 1. To determine if low maternal DHA status in gestation is related to child development at 5 years of age; 2. To determine the DHA status of children 5 years-of-age in relation to scores on tests of development; 3. To identify the dietary patterns that place children at risk for poor DHA status; 4. To assess if genetic variation in fatty acid metabolism alters blood lipid fatty acids in children This research is a prospective follow-up of 209 children that were last assessed at age 18 months and for whom maternal DHA status in gestation is known. The children with their parents are invited to attend our nutrition lab at the Child and Family Research Institute where the child will complete play-like developmental assessments. Measurement of blood pressure, heart rate, height and weight will be completed and blood samples will be collected to measure DHA, other relevant nutrient that impact development and genetic variables relevant to fatty acids. The parent will provide information on the child' diet and health. Baseline characteristics for the subjects will be summarized using descriptive statistics. Logistic regression will be used to assess the relationship of DHA status to cognitive development with multi-variable-adjusted odds ratios (ORs) of a negative outcome and corresponding 95% confidence interval (CI). Regressions will also be run with the outcomes in continuous form to assess the changes in scores associated with increments of child DHA status. For all multivariate regression models, potential confounders will be screened in stepwise fashion, and any covariate with a regression coefficient P-value < 0.05 (two-sided) will be retained. Variables will include gender, birth weight, gestation length, maternal intelligence quotient (IQ), ethnicity, breast-feeding duration, birth order, and dichotomized variables of child health, eating behavior and martial status. Children will grouped in quintiles of DHA status and descriptive statistics will be used to present intakes of total fat, individual fatty acids. ANOVA will be used to determine if genetic variables influence blood DHA status.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V5Z4H4
- Child & Family Research Institute, Nutrition and Metabolism Research Program
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Mothers who participated in study (REB # C03-0242 and C&W W03-0084)
- who have already provided written consent for re-contact to participate with their 5 year old child.
Exclusion Criteria:
- Mothers who did not participate in the previous study "N-3 fatty acid requirements for human development"
- Mothers who have not provided written consent for re-contact.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
maternal DHA status in gestation
Time Frame: 16 & 36 weeks gestation
|
red blood cell DHA biochemistries
|
16 & 36 weeks gestation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
plasma lutein and Red blood cell DHA
Time Frame: 5 years 8 months to 6 years
|
plasma lutein and red blood cell DHA biochemistries
|
5 years 8 months to 6 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
cognitive development with standardized developmental tests
Time Frame: 5 years 8 months to 6 years
|
Assessment with the Kaufman Developmental Assessment Battery
|
5 years 8 months to 6 years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Tim Oberlander, MD, University of British Columbia
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- H09-01633
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Docosahexanoic Acid (DHA) Status
-
Maartje van den BeltUtrecht University; Nutricia Research; Fermentalg; Microalgas Oleas de México,...Not yet recruitingFatty Acid Metabolism | Functional Immune Response | Postprandial Bioavailability DHANetherlands
-
Ludwig-Maximilians - University of MunichEuropean UnionCompletedPerinatal DHA and Folate Status | Neurological DevelopmentHungary, Germany, Spain
-
Research Institute of Child Nutrition, DortmundCompletedIron Status | Fatty Acid StatusGermany
-
Research Institute of Child Nutrition, DortmundUniversity of Potsdam; Dr. von Hauner Children's Hospital, Germany; Pediatric...Completed
-
University of UlsterLund University; University of Rochester; Ministry of Health, Republic of SeychellesCompletedPolyunsaturated Fatty Acid (PUFA) StatusUnited Kingdom
-
University of MostarFaculty of Health Studies - University of Mostar; Primary Health Care Center... and other collaboratorsRecruitingMicronutrient Status in Women of Reproductive Age | Vitamin Status Assessment | Vitamin D, Vitamin B 12 and Folic Acid ConcentrationsBosnia and Herzegovina
-
University of MostarRecruitingVitamin d, Vitamin B 12 and Folic Acid Concentrations | Micronutrient Status in Women of Reproductive Age | Vitamin Status AssessmentBosnia and Herzegovina
-
Warsaw University of Life SciencesWroclaw Medical University; National Science Centre, Poland; National Institute...Not yet recruitingBody Weight | Body Composition | Growth & Development | Adipokines | Carotenoid Status | Obesity & Overweight | Metabolomic Profile | Vitamin E | Inflammation Biomarkers | Human Milk/Breastfeeding | Immunologic Markers | Fatty Acid Status | Infant Body Composition and Metabolism | Maternal Cardiometabolic HealthPoland, Canada
-
University of NottinghamCompletedOxidative Stress | Hepatic Fatty Acid Metabolism | Systemic Insulin Resistance | Cardiovascular StatusUnited Kingdom
-
Nutrition Institute, SloveniaNational Institute of Public Health, Slovenia; University Medical Centre LjubljanaCompletedThyroid Diseases | Iron-deficiency | Vitamin D Deficiency | Nutritional Status | Vitamin B 12 Deficiency | Folic Acid Deficiency | Diet | Nutrient Deficiency | Micronutrient DeficiencySlovenia